In this context, we evaluated the differential methylation pattern of the candidate genes SOCS3, SREBF1, and TXNIP between T2DM patients and controls, and found the presence of an altered methylation profile only for the SOCS3 gene. The gene discussed is SOCS3; the disease is type 2 diabetes mellitus.